PHARMACEUTICALS PRODUCTS

Brand Owner (click to sort) Address Description
ALTERIX Biochemics 99 Rosewood Drive suite 270 Danvers MA 01923 Pharmaceuticals products, namely, lotions, gels and ointments for the treatment of arthritic and neuropathic pain;
AVALENT NYCOMED GMBH Byk-Gulden-Str. 2 D-78467 Konstanz Germany Pharmaceuticals products, namely, preparations for the treatment of gastro-intestinal diseases and conditions, preparations for the treatment of respiratory diseases and conditions, preparations for the treatment of cancer, analgesic preparations, anti-rheumatic preparations, anti-inflammatory preparations, antiallergic preparations and antiphlogistic preparations, preparations for the treatment of osteoporosis;
DEKEL THERAPEUTICS Dekel Therapeutics, Inc. 184 East Emerson Road Lexington MA 02420 Pharmaceuticals products;
DUSODRIL LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE 34, rue Saint-Romain 69008 LYON France pharmaceuticals products, namely peripheral and cerebral anti-ischemics and vasodilatators;
MUTABILIS Mutabilis 84 rue de Grenelle Paris 75007 France Pharmaceuticals products, namely pharmaceutical preparations used for the treatment of infectious and/or inflammatory diseases, central nervous system, vaccines; medical diagnostic reagents, vaccines;
REANDRON BAYER SCHERING PHARMA AKTIENGESELLSCHAFT MULLERSTRASSE 178 BERLIN 13353 Germany Pharmaceuticals products, namely, hormonal preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Disclosed is a process wherein a first olefin selected from certain ?,?-dihydroxyalkenes and 4-(alkenyl)ethylenecarbonates is reacted with a second olefin reactant to produce an olefin metathesis product. When the first olefin reactant is an optically enriched or enantiomerically pure ?,?-dihydroxyalkene, cross metathesis reactions produce products possessing the same optical purity. The ?,?-dihydroxyalkenes and the 4-(alkenyl)ethylene carbonates may be converted to hydrogenated products, and the 4-(alkenyl)ethylenecarbonates may be decarboxylated to provide the corresponding epoxides. The products of the disclosure may be used as monomers for the preparation of specialty polyesters and as intermediates in the manufacture pharmaceuticals and other chemicals.